Tisa-Cel Yields Durable Responses in R/R Follicular Lymphoma
Our panel of experts discuss 3-year findings from the phase II ELARA study
Source: medpagetoday.com
Page 5 - Greg Laub News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Greg Laub. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Greg Laub Today - Breaking & Trending Today
MedPod Today: Long COVID and Stem Cells; An Unusual Pregnancy; New Cannabinoids
<em>MedPage Today</em> reporters offer further insights on these recently covered topics
Source: medpagetoday.com
SABCS 2023 Highlights Open the Door for More Key Data in 2024
Virginia Kaklamani, MD, discusses this year's sessions of interest and looks ahead to next year
Source: medpagetoday.com
Responses to Mosunetuzumab in Follicular Lymphoma Remain Durable at 3 Years
Bispecific antibody also shows high response rates in frontline setting
Source: medpagetoday.com
Early Detection Is Key to Higher Cure Rates in Ovarian Cancer
'We are not aware of precancer stages for ovarian cancer'
Source: medpagetoday.com